Search All News
Among young adults who smoke cigarettes, vaping may increase daily cigarette smoking and deter quitting, a new study by Columbia psychiatrists has found.
A new generation of transgender youth and adults is rejecting the traditional binary model of gender identity, says Walter Bockting of Columbia’s Gender Identity Program.
A new study suggests that antidepressants may control symptoms of schizophrenia better than other types of psychiatric drugs when combined with antipsychotic drugs.
A new study of elderly Hispanics found that hearing loss increased the risk of depression symptoms.
- April 28, 2017
Neuronal branches become tangled in mice lacking Pcdh genes, leading to signs of depression or sensory deficits when specific genes are absent, studies find.
- April 28, 2017
Illicit cannabis use and cannabis use disorders increased at a greater rate in states that passed medical marijuana laws than in other states, a new study finds.
- April 14, 2017
A breakdown in the synchronized behavior of some neurons may produce schizophrenia symptoms, according to a new study of a mouse model of the disorder.
- April 5, 2017
Columbia University and Weill Cornell announce Takao Hensch, PhD, as this year's recipient of the Mortimer D. Sackler, MD Prize, which recognizes leaders in developmental psychobiology.
- March 21, 2017
American adults who survive deliberate self-harm—particularly with a firearm—are at increased risk of suicide in the short term, according to a new study from Columbia University Medical Center.
- January 23, 2017
The Chapman Perelman Foundation has contributed $1 million to Columbia Psychiatry to expand an initiative that provides mental health services to victims of domestic violence.
- January 6, 2017
Columbia researchers have found that psychiatric brain imaging studies often exclude many of the people who are living with these disorders.
- December 2, 2016
Columbia research finds that people with schizophrenia who have difficulty hearing subtle changes in pitch may be helped with auditory training and a drug targeting NMDA receptors.